Wei Huang

Dr. Wei Huang

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 February 2021 in Frontiers in Cellular and Infection Microbiology
Verified
Journal Article
Open access
XTXin Tan
Xin Tan
HCHuaisheng Chen
Huaisheng Chen
MZMin Zhang
Min Zhang
YZYing Zhao
Ying Zhao
YJYichun Jiang
Yichun Jiang
YMYingfei Ma
Yingfei Ma
Overuse of antibiotics in clinical medicine has contributed to the global spread of multidrug-resistant bacterial pathogens, includingAcinetobacter baumannii. We present a case of an 88-year-old Chinese man who developed hospital-acquired pneumonia caused by carbapenem-resistantA. baumannii(CRAB). A personalized lytic pathogen-specific single-phage preparation was nebulized to the patient continuously for 16 days in combination with tigecycline and polymyxin E. The treatment was well tolerated and resulted in clearance of the pathogen and clinical improvement of the patient’s lung function.

1 December 2017 in Tuberculosis
Verified
Journal Article
Closed access
JBJulien Briffotaux
Julien Briffotaux
WHWei Huang
Wei Huang
XWXinwei Wang
Xinwei Wang
BGBrigitte Gicquel
Brigitte Gicquel

1 January 2021 in International Journal of Biological Sciences
Verified
Journal Article
Open access
QTQian Tang
Qian Tang
YWYue Wang
Yue Wang
LOLing Ou
Ling Ou
JLJieling Li
Jieling Li
KZKai Zheng
Kai Zheng
XWXiao Wang
Xiao Wang
Background: Angiotensin-converting enzyme 2 (ACE2) and transmembrane serine protease 2 (TMPRSS2) allow entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into host cells and play essential roles in cancer therapy. However, the functions of ACE2 and TMPRSS2 in kidney cancer remain unclear, especially as kidneys are targets for SARS-CoV-2 infection.

1 February 2024 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
PDF file
CHChengying Hong
Chengying Hong
YXYihan Xiong
Yihan Xiong
JXJinquan Xia
Jinquan Xia
WHWei Huang
Wei Huang
AXAndi Xia
Andi Xia
ZZZhongwei Zhang
Zhongwei Zhang
Objective: The objective of this study was to utilize LASSO regression (Least Absolute Shrinkage and Selection Operator Regression) to identify key variables in septic patients and develop a predictive model for intensive care unit (ICU) mortality. Methods: We conducted a cohort consisting of septic patients admitted to the ICU between December 2016 and July 2019. The disease severity and laboratory index were analyzed using LASSO regression. The selected variables were then used to develop a model for predicting ICU mortality. AUCs of ROCs were applied to assess the prediction model, and the accuracy, sensitivity and specificity were calculated. Calibration were also used to assess the actual and predicted values of the predictive model. Results: A total of 1733 septic patients were included, among of whom 382 (22%) died during ICU stay. Ten variables, namely mechanical ventilation (MV) requirement, hemofiltration (HF) requirement, norepinephrine (NE) requirement, septicemia, multiple drug-resistance infection (MDR), thrombocytopenia, hematocrit, red-cell deviation width coefficient of variation (RDW-CV), C-reactive protein (CRP), and antithrombin (AT) III, showed the strongest association with sepsis-related mortality according to LASSO regression. When these variables were combined into a predictive model, the area under the curve (AUC) was found to be 0.801. The AUC of the validation group was 0.791. The specificity of the model was as high as 0.953. Within the probability range of 0.25 to 0.90, the predictive performance of the model surpassed that of individual predictors within the cohort. Conclusion: Our findings suggest that a predictive model incorporating the variables of MV requirement, HF requirement, NE requirement, septicemia, MDR, thrombocytopenia, HCT, RDW-CV, CRP, and AT III exhibiting an 80% likelihood of predicting ICU mortality in sepsis and demonstrates high accuracy.

1 March 2014 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
WHWei Huang
Wei Huang
YQYingjie Qi
Yingjie Qi
YDYujie Diao
Yujie Diao
FYFei Yang
Fei Yang
XZXiaodan Zha
Xiaodan Zha
JSJijia Shen
Jijia Shen

1 January 2022 in BioMed Research International
Verified
Journal Article
Open access
PDF file
RCRuihuan Chai
Ruihuan Chai
MLMin Liao
Min Liao
LOLing Ou
Ling Ou
QTQian Tang
Qian Tang
YLYoufang Liang
Youfang Liang
SWShaoxiang WANG
Shaoxiang WANG
Gliomas are the most common primary intracranial tumors and closely related to circadian clock. Due to the high mortality and morbidity of gliomas, exploring novel diagnostic and early prognostic markers is necessary. Circadian clock genes (CCGs) play important roles in regulating the daily oscillation of biological processes and the development of tumor. Therefore, we explored the influences that the oscillations of circadian clock genes (CCGs) on diagnosis and prognosis of gliomas using bioinformatics. In this work, we systematically analyzed the rhythmic expression of CCGs in brain and found that some CCGs had strong rhythmic expression; the expression levels were significantly different between day and night. Four CCGs (ARNTL, NPAS2, CRY2, and DBP) with rhythmic expression were not only identified as differentially expressed genes but also had significant independent prognostic ability in the overall survival of glioma patients and were highly correlated with glioma prognosis in COX analysis. Besides, we found that CCG‐based predictive model demonstrated higher predictive accuracy than that of the traditional grade‐based model; this new prediction model can greatly improve the accuracy of glioma prognosis. Importantly, based on the four CCGs’ circadian oscillations, we revealed that patients sampled at night had higher predictive ability. This may help detect glioma as early as possible, leading to early cancer intervention. In addition, we explored the mechanism of CCGs affecting the prognosis of glioma. CCGs regulated the cell cycle, DNA damage, Wnt, mTOR, and MAPK signaling pathways. In addition, it also affects prognosis through gene coexpression and immune infiltration. Importantly, ARNTL can rhythmically modulated the cellular sensitivity to clinic drugs, temozolomide. The optimal point of temozolomide administration should be when ARNTL expression is highest, that is, the effect is better at night. In summary, our study provided a basis for optimizing clinical dosing regimens and chronotherapy for glioma. The four key CCGs can serve as potential diagnostic and prognostic biomarkers for glioma patients, and ARNTL also has obvious advantages in the direction of glioma chronotherapy.